Listeria-vectored multi-antigenic tuberculosis vaccine protects C57BL/6 and BALB/c mice and guinea pigs against Mycobacterium tuberculosis challenge

Mycobacterium tuberculosis (Mtb) infects one-third of the world’s population and is a leading cause of death from a single infectious agent. New TB vaccines are urgently needed to augment immunity conferred by the current modestly protective BCG vaccine. We have developed live attenuated recombinant...

Descripción completa

Detalles Bibliográficos
Autores principales: Jia, Qingmei, Masleša-Galić, Saša, Nava, Susana, Horwitz, Marcus A.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Nature Publishing Group UK 2022
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9764316/
https://www.ncbi.nlm.nih.gov/pubmed/36539517
http://dx.doi.org/10.1038/s42003-022-04345-1

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9764316/
https://www.ncbi.nlm.nih.gov/pubmed/36539517
http://dx.doi.org/10.1038/s42003-022-04345-1

Ejemplares similares